Patent holdings for IPC class A61K 31/4709

Total number of patents in this class: 5748

10-year publication summary

401
368
447
437
429
439
382
364
446
265
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026

Principal owners for this class

Owner
All patents
This class
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
777
90
Centre National de La Recherche Scientifique
11055
61
The Regents of the University of California
20802
58
Janssen Pharmaceutica N.V.
3161
56
Bristol-myers Squibb Company
4748
53
Boehringer Ingelheim International GmbH
4483
48
Gilead Sciences, Inc.
2231
47
Arog Pharmaceuticals, Inc.
53
46
Vertex Pharmaceuticals Incorporated
1579
44
F. Hoffmann-La Roche AG
7815
42
Kura Oncology, Inc.
133
38
Universite de Montpellier
1046
37
Novartis AG
10178
36
Institut Curie
618
35
Merck Sharp & Dohme LLC
3736
35
Abivax
135
34
Forma Therapeutics, Inc.
147
34
Merck Patent GmbH
5735
33
Shanghai Institute of Materia Medica, Chinese Academy of Sciences
875
33
Amgen Inc.
4436
32
Other owners 4856